Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model
Open Access
- 20 August 2004
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 2 (1) , 30
- https://doi.org/10.1186/1741-7015-2-30
Abstract
Background: Pendred syndrome, a common autosomal-recessive disorder characterized by congenital deafness and goiter, is caused by mutations of SLC26A4, which codes for pendrin. We investigated the relationship between pendrin and deafness using mice that have (Slc26a4+/+) or lack a complete Slc26a4 gene (Slc26a4-/-). Methods: Expression of pendrin and other proteins was determined by confocal immunocytochemistry. Expression of mRNA was determined by quantitative RT-PCR. The endocochlear potential and the endolymphatic K+ concentration were measured with double-barreled microelectrodes. Currents generated by the stria marginal cells were recorded with a vibrating probe. Tissue masses were evaluated by morphometric distance measurements and pigmentation was quantified by densitometry. Results: Pendrin was found in the cochlea in apical membranes of spiral prominence cells and spindle-shaped cells of stria vascularis, in outer sulcus and root cells. Endolymph volume in Slc26a4-/- mice was increased and tissue masses in areas normally occupied by type I and II fibrocytes were reduced. Slc26a4-/- mice lacked the endocochlear potential, which is generated across the basal cell barrier by the K+ channel KCNJ10 localized in intermediate cells. Stria vascularis was hyperpigmented, suggesting unalleviated free radical damage. The basal cell barrier appeared intact; intermediate cells and KCNJ10 mRNA were present but KCNJ10 protein was absent. Endolymphatic K+ concentrations were normal and membrane proteins necessary for K+ secretion were present, including the K+ channel KCNQ1 and KCNE1, Na+/2Cl-/K+ cotransporter SLC12A2 and the gap junction GJB2. Conclusions: These observations demonstrate that pendrin dysfunction leads to a loss of KCNJ10 protein expression and a loss of the endocochlear potential, which may be the direct cause of deafness in Pendred syndrome.Keywords
This publication has 43 references indexed in Scilit:
- Metabolic Regulation of Potassium ChannelsAnnual Review of Physiology, 2004
- Expression of Na+/I- Symporter and Pendred Syndrome Genes in Trophoblast CellsJournal of Clinical Endocrinology & Metabolism, 2000
- Expression of Pendrin and the Pendred Syndrome (PDS) Gene in Human Thyroid TissuesJournal of Clinical Endocrinology & Metabolism, 2000
- Quantification of insulin-like growth factor-1 (IGF-1) mRNA: Development and validation of an internally standardised competitive reverse transcription-polymerase chain reactionExperimental and Clinical Endocrinology & Diabetes, 1998
- Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS)Nature Genetics, 1997
- Differential cellular distribution of glutathione – an endogenous antioxidant – in the guinea pig inner earBrain Research, 1996
- Development of endocochlear potential and its negative component in mouse cochleaHearing Research, 1995
- Hyperpigmentation of Chinchilla Stria Vascularis Following Acoustic TraumaPigment Cell Research, 1992
- The ultrastructural cytochemistry of peroxisomes in the guinea pig cochlea: A metabolic hypothesis for the stria vascularisThe Laryngoscope, 1979
- DEAF-MUTISM AND GOITRE.The Lancet, 1896